Applied dna and takis biotech/evvivax to launch clinical trial for veterinary use of linear covid-19 vaccine candidate

Applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the
APDN Ratings Summary
APDN Quant Ranking